AbbVie Inc. (ABBV)

Trade Timeline

Risk Factors

• •Expected capture for the recommended quick-capture setup (Buy 7d / Sell 1d) is low at 0.14% with only a modest win rate of 55.8%.
• •Average capture yield of 0.993% vs. the single dividend of $1.73 (~0.76% of price) implies variability around ex-date price moves; profit is not guaranteed.
• •Average recovery time of 20.7 days means short holding periods can be exposed to drawdowns before typical post-dividend rebound.
• •20-day momentum slope is slightly negative (-0.0086% per day), which partially offsets the marginally positive 5-day slope (0.0234% per day) and introduces trend risk.
• •14-day ATR of 2.12% versus a small expected edge (≤0.5% in most scenarios) means normal price volatility can easily overwhelm the statistical advantage.
• •Medium overall confidence and Tier 3 quality suggest that company- or sector-specific news around the ex-date could materially impair the capture outcome.

Action Checklist

• 1.Confirm $ABBV still trades near $228.49 and that the 2026-01-16 ex-dividend date and $1.73 amount are unchanged before acting.
• 2.If pursuing long-term income, size $ABBV as a secondary position and pair it with higher-quality, higher-score dividend holdings.
• 3.If pursuing a capture trade, decide between: (a) Buy 7 days before / Sell 1 day after ex-date (historically recommended quick-capture setup, 0.14% expected return), or (b) Buy 1 day before / Sell 7–14 days after (historically higher average returns of 0.43–0.56% with ~54% win rate).
• 4.Align entry around the chosen timing window, favoring intraday weakness; avoid chasing if the price runs significantly above recent levels.
• 5.Set a clear exit plan in advance (time-based and/or small profit/stop-loss thresholds) recognizing that 14-day ATR of 2.12% can easily exceed the statistical edge.
• 6.Monitor for company or sector news between now and the ex-date that could invalidate the medium-confidence historical patterns.
• 7.Review position sizing to ensure that a normal 2–3% price swing does not create outsized portfolio risk relative to the limited expected capture gain.